| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |